Chelsea Therapeutics International Ltd. Third Quarter Earnings Sneak Peek

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) will unveil its latest earnings on Wednesday, November 2, 2011. Chelsea Therapeutics International is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of innovative pharmaceutical products.

Chelsea Therapeutics International Ltd. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net loss of 27 cents per share, a wider loss from the year earlier quarter net loss of 22 cents. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month.

Past Earnings Performance: The company beat estimates last quarter after falling short in the prior two. In the second quarter, the company reported a loss of 22 cents per share versus a mean estimate of net loss of 25 cents per share. In the first quarter, the company missed estimates by 2 cents.

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.

Analyst Ratings: Analysts are bullish on this stock with six analysts rating it as a buy, none rating it as a sell and none rating it as a hold.

A Look Back: In the second quarter, the company’s loss widened to a loss of a $13.3 million (21 cents a share) from a loss of $9.9 million (25 cents) a year earlier, but beat analyst expectations. Revenue was unchanged at $0.0.

Key Stats:

Competitors to Watch: Mylan Inc. (NASDAQ:MYL), Impax Laboratories, Inc. (NASDAQ:IPXL), Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA), Johnson & Johnson (NYSE:JNJ), Bristol Myers Squibb Co. (NYSE:BMY), Abbott Laboratories (NYSE:ABT), Pfizer Inc. (NYSE:PFE), Novartis AG (NYSE:NVS), Amgen, Inc. (NASDAQ:AMGN), and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL).

Stock Price Performance: During September 29, 2011 to October 27, 2011, the stock price had risen 87 cents (22.4%) from $3.89 to $4.76. The stock price saw one of its best stretches over the last year between September 9, 2011 and September 16, 2011 when shares rose for six-straight days, rising 10% (+41 cents) over that span. It saw one of its worst periods between July 28, 2011 and August 8, 2011 when shares fell for eight-straight days, falling 31.5% (-$1.64) over that span. Shares are down $2.74 (-36.5%) year to date.

(Source: Xignite Financials)

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.